Koshinski Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Koshinski Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,409	Closed	-$184K	–	1212
2022 Q1	$184K	Hold	1,409	–	–	0.02%	616
2021 Q4	$215K	Sell	1,409 -465	-25%	-$72K	0.02%	602
2021 Q3	$303K	Buy	+1,874	New	+$315K	0.03%	507
2021 Q2	–	Sell	-2,590	Closed	-$390K	–	585
2021 Q1	$390K	Buy	2,590 +30	+1%	+$4.76K	0.04%	412
2020 Q4	$388K	Sell	2,560 -9	-0.4%	-$1.29K	0.05%	377
2020 Q3	$369K	Buy	2,569 +399	+18%	+$54.1K	0.05%	361
2020 Q2	$297K	Buy	+2,170	New	+$277K	0.05%	390
2020 Q1	–	Sell	-1,816	Closed	-$218K	–	484
2019 Q4	$218K	Buy	+1,816	New	+$203K	0.04%	464
2019 Q1	–	Sell	-2,950	Closed	-$284K	–	429
2018 Q4	$284K	Sell	2,950 -1,845	-38%	-$196K	0.07%	313
2018 Q3	$585K	Sell	4,795 -422	-8%	-$49.7K	0.08%	293
2018 Q2	$573K	Sell	5,217 -249	-5%	-$26.6K	0.17%	183
2018 Q1	$583K	Buy	+5,466	New	+$606K	0.18%	186
2017 Q4	–	Sell	-8,859	Closed	-$985K	–	424
2017 Q3	$985K	Sell	8,859 -2,049	-19%	-$219K	0.32%	97
2017 Q2	$1.13M	Sell	10,908 -8,430	-44%	-$830K	0.41%	78
2017 Q1	$1.89M	Buy	19,338 +10,236	+112%	+$980K	0.74%	33
2016 Q4	$805K	Sell	9,102 -23,829	-72%	-$2.17M	0.4%	85
2016 Q3	$2.04M	Buy	32,931 +21,582	+190%	+$2.05M	1.01%	16
2016 Q2	$974K	Sell	11,349 -4,266	-27%	-$383K	0.53%	51
2016 Q1	$1.36M	Buy	15,615 +10,470	+203%	+$936K	0.88%	22
2015 Q4	$580K	Buy	5,145 +231	+5%	+$25.1K	0.41%	77
2015 Q3	$604K	Buy	4,914 +21	+0.4%	+$2.52K	0.39%	77
2015 Q2	$602K	Buy	4,893 +885	+22%	+$106K	0.38%	78
2015 Q1	$459K	Buy	+4,008	New	+$442K	0.3%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Koshinski Asset Management's IBB Position: Q2 2022 in Review

Koshinski Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 1,409 shares — an estimated $184K sold.

Koshinski Asset Management first reported a position in IBB in Q1 2015 and held it in 23 quarters. The position peaked at $2.04M in Q3 2016. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Koshinski Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 1,409 iShares Biotechnology ETF shares in Q2 2022, an estimated $184K.
Koshinski Asset Management first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 23 quarters.
Koshinski Asset Management's iShares Biotechnology ETF position peaked at $2.04M in Q3 2016.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.